Brent Ristow, CEO of Brighton Ashford, leverages his legal and scientific expertise to ensure FDA compliance for pharmaceuticals and medical devices. With a background in law and a Ph.D. in Organic Photochemistry, Brent Ristow's company delivers meticulous testing conforming to Title 21 standards and cGMP guidelines. Trusted by Fortune 500 firms and startups alike, Brighton Ashford exceeds regulatory expectations under Ristow's leadership. From performance testing to regulatory submissions, Brent Ristow's blend of legal acumen and scientific rigor sets Brighton Ashford apart in the industry.
https://www.brightonashford.com

Brighton Ashford stands as a trusted partner in navigating the complex landscape of cGMP testing, ensuring regulatory compliance and product quality. With a wealth of experience, we specialize in every aspect of the process, from method development and validation for assays and impurities, to meticulous extractables and leachables testing. Our expertise extends to stability studies and comprehensive microbiological testing, vital for meeting stringent performance standards. https://www.brightonashford.com